Peripheral Arterial Disease News and Research

RSS

Exposure to household chemical may raise cardiac risk

Exposure to perfluorooctanoic acid may be associated with cardiovascular disease and peripheral arterial disease, say researchers.

5 Sep 2012

Exposure to perfluorooctanoic acid appears to increase risk of CVD and peripheral arterial disease

Exposure to perfluorooctanoic acid (PFOA), a manmade chemical used in the manufacture of some common household products, appears to be associated with cardiovascular disease and peripheral arterial disease in a study of 1,216 individuals, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

4 Sep 2012

Gene therapy applied to peripheral arterial disease

Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.

21 Aug 2012

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis patients with and without diabetes are at risk for foot ulceration, say UK researchers who believe preventive resources must be directed towards both patient groups.

20 Aug 2012

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis patients with and without diabetes are at risk for foot ulceration, say UK researchers who believe preventive resources must be directed toward both patient groups.

16 Aug 2012

Depressed cardiac patients at added risk

Coronary artery disease patients may have an increased risk for peripheral arterial disease if they are depressed, study findings show.

14 Aug 2012

Depressed cardiac patients at added risk

Coronary artery disease patients may have an increased risk for peripheral arterial disease if they are depressed, study findings show.

10 Aug 2012

Prior contralateral amputation predicts outcomes after LEB for critical limb ischemia

Researchers from the Vascular Study Group of New England (VSGNE) report that prior contralateral amputation predicts worse outcomes for lower extremity bypasses (LEB's) performed in the intact limb.

6 Aug 2012

Bard completes enrollment in Lutonix DCB clinical trial for peripheral arterial disease

C. R. Bard, Inc. today announced that its Lutonix technology center completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial.

26 Jul 2012

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.

17 Jul 2012

FDA clears TMI’s Glider PTCA balloon catheter

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its unique Glider PTCA balloon catheter.

16 Jul 2012

Peripheral arterial disease predicts mortality in TAVI patients

Patients with severe aortic stenosis who undergo transcatheter aortic valve implantation are at particularly high risk for complications and death if they also have concomitant peripheral arterial disease, study results show.

10 Jul 2012

Atkins diet ‘dangerous to heart health’

Women who follow an Atkins-style diet have a significantly increased risk for cardiovascular disease, experts warn.

28 Jun 2012

Cardiovascular disease risk greater with Atkins-style diets

Women who regularly eat a low carbohydrate, high protein diet are at greater risk of cardiovascular disease (such as heart disease and stroke) than those who do not, a study published on bmj.com today suggests.

27 Jun 2012

Clinical study to examine retrograde tibiopedal interventional approach for CLI

Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50 percent in patients with critical limb ischemia (CLI), a manifestation of peripheral arterial disease (PAD).

26 Jun 2012

FDA clears expanded matrix of sizes for TMI's Chocolate PTA balloon catheter

TriReme Medical, Inc. announced today that it has received FDA clearance for an expanded matrix of sizes for its Chocolate PTA balloon catheter. Chocolate is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2.0 - 4.0mm and in balloon lengths up to 120mm.

19 Jun 2012

Study assesses impact of postoperative nHb and transfusion in patients with PAD

Vascular surgeons from Baylor College of Medicine and the Michael E. DeBakey Veterans' Administration Medical Center in Houston, TX, have released a study about the impact of transfusion and postoperative nadir postoperative hemoglobin (nHb) on short- and long-term outcomes after interventions for peripheral arterial disease.

8 Jun 2012

FDA approves TMI’s Glider PTCA Catheter

TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.

23 May 2012

Proper care of diabetic foot infections can save limbs, lives

Diabetic foot infections are an increasingly common problem, but proper care can save limbs and, ultimately, lives, suggest new guidelines released by the Infectious Diseases Society of America.

23 May 2012

LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care

In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart attacks, strokes and other heart events for women and people of color.

19 May 2012